Malignant Hyperthermia
Hypermetabolic crisis triggered by halogenated volatiles or succinylcholine.
Recognize
- Unexplained ↑↑ EtCO₂ (most sensitive & specific early sign)
- Tachycardia, tachypnea
- Muscle rigidity (esp. masseter after sux)
- Mixed metabolic / respiratory acidosis
- Hyperthermia — LATE sign (1–2 °C every 5 min)
- Dark urine (myoglobinuria), hyperkalemia
Doses
Sequenced Actions
- 1STOP triggers
- Stop all volatile anesthetics and succinylcholine
- Switch to TIVA (propofol + opioid + non-depolarizing NMBA)
- High-flow O₂ 10 L/min via clean circuit (or charcoal filter); change CO₂ absorbent
- 2Hyperventilate
- 100% FiO₂, increase minute ventilation 2–3× to blow off CO₂
- 3Call for help
- Call MHAUS hotline: 1-800-MH-HYPER (1-800-644-9737)
- Mobilize additional staff (need many hands to mix old dantrolene)
- Get the MH cart to the room
- 4Dantrolene
- 2.5 mg/kg IV bolus every 5 min until reaction abates
- Often need 10 mg/kg total; up to 30 mg/kg possible
- Ryanodex (250 mg vial in 5 mL sterile water) — fast prep
- Old dantrolene: 20 mg vial + mannitol in 60 mL sterile water — slow prep, need help
- Continue 1 mg/kg IV q6h × 24–48 h after acute event
- 5Cool the patient
- Cold saline IV (avoid LR)
- Ice packs to axillae, groin
- Lavage open cavities, NG, bladder with cold fluid
- Stop cooling at 38 °C to avoid overshoot hypothermia
- 6Treat hyperkalemia
- Calcium chloride 1 g IV (central) or Ca gluconate 1–2 g (peripheral)
- Insulin 10 units IV + D50 25 g
- Sodium bicarbonate 50–100 mEq IV
- Albuterol nebulized
- AVOID calcium channel blockers with dantrolene — risk of cardiovascular collapse
- 7Treat dysrhythmias & acidosis
- Standard antiarrhythmics (avoid CCBs)
- Sodium bicarbonate for acidosis
- Maintain UOP > 1 mL/kg/h (consider mannitol, furosemide) to prevent myoglobinuria-induced AKI
- 8ICU transfer
- 24–48 h ICU monitoring — recrudescence in ~25%
- Repeat CK, K⁺, myoglobin, BUN/Cr, coags
- Refer for MH testing; counsel family (first-degree relatives 50% risk)
- Add to MHAUS registry, issue MedicAlert
Common Pitfalls
- Confusing late hyperthermia with normal heat retention — CO₂ rises first.
- Giving verapamil or other CCB with dantrolene → cardiovascular collapse.
- Failing to mobilize enough staff to mix old dantrolene formulation quickly.
- Missing recrudescence in PACU/ICU — must monitor 24–48 h.
References & Further Reading
- 1SocietyOpen source
Malignant Hyperthermia Association of the United States (MHAUS). Recognition and Treatment of MH. Hotline 1-800-MH-HYPER. mhaus.org.
- 2WebOpen source
Stanford Anesthesia Cognitive Aid Group. Stanford Anesthesia Emergency Manual. emergencymanual.stanford.edu.
- 3Textbook
Gropper MA, Miller RD, Cohen NH, et al., eds. Miller's Anesthesia. 9th ed. Philadelphia: Elsevier; 2020.
- 4Textbook
Flood P, Rathmell JP, Shafer S. Stoelting's Pharmacology and Physiology in Anesthetic Practice. 5th ed. Philadelphia: Wolters Kluwer; 2015.
- 5Textbook
Adriano A, Morris R, eds. 2021 CA-1 Tutorial Textbook (15th Ed.). Stanford University Medical Center, Department of Anesthesiology.
Citations are provided to direct further study. Always check the most current edition of guidelines and society recommendations — the information in this chapter is a teaching summary, not primary source material.